IMRNW (Immuron) Total Stockholders Equity : $6.55 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Immuron Total Stockholders Equity?

Immuron's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $6.55 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Immuron's Book Value per Share for the quarter that ended in Dec. 2024 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Immuron's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.00.

Immuron Total Stockholders Equity Historical Data

The historical data trend for Immuron's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Total Stockholders Equity Chart

Immuron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Stockholders Equity

Get a 7-Day Free Trial

3.90

19.80

16.29

13.17

8.44

Immuron Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial													14.35	13.17	11.73	8.44	6.55

Immuron (NAS:IMRNW) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Immuron's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6.548	-	0)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Immuron's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	6.548
	=	0.00

Immuron Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Immuron's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (NAS:IMRNW) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

IMRN:USA IMC:Australia

Address

Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130

Website

https://www.immuron.com.au

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.